We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.20 | 1.17% | 189.80 | 189.40 | 190.40 | 190.00 | 187.40 | 189.20 | 90,923 | 10:50:12 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 25.93 | 412.27M |
TIDMAMS
RNS Number : 5156F
Advanced Medical Solutions Grp PLC
10 March 2020
10 March 2020
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:
Name of applicant: Advanced Medical Solutions Group plc Name of scheme: Block Scheme for: 1. Deferred Share Bonus Scheme 2. Enterprise Management Incentive Scheme 3. Company Share Option Plan 4. Unapproved Executive Share Option Scheme 5. Long Term Incentive Plan 6. Deferred Annual Bonus Scheme ------------------------------------------------------------- Period of return: From: 6 September 2019 To: 6 March 2020 ----------------------- ----------------------------- ------- --------------------- Balance of unallotted securities under scheme(s) from 1. 661,554 previous return: 2. 38,000 3. 323,733 4. 1,037,228 5. 776,034 6. 407,111 ------------------------------------------------------------- Plus: The amount by which the block scheme(s) has been 1. Nil increased since the date of the last 2. Nil return (if any increase has been applied for): 3. Nil 4. Nil 5. Nil 6. Nil ------------------------------------------------------------- Less: Number of securities issued/allotted under 1. 34,463 scheme(s) during period: 2. 23,000 3. Nil 4. 83,031 5. Nil 6. Nil ------------------------------------------------------------- Equals: Balance under scheme(s) not yet 1. 627,091 issued/allotted at end of period: 2. 15,000 3. 323,733 4. 954,197 5. 776,034 6. 407,111 ------------------------------------------------------------- Number and class of securities originally listed and 4,476,264 ordinary shares of 5p each on 6 September 2018 the date of admission: ------------------------------------------------------------- Name of contact: Eddie Johnson Telephone number of contact: 01606 545506 --------------
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606 545508 Chris Meredith, Chief Executive Officer Eddie Johnson, Chief Financial Officer Consilium Strategic Communications Tel: +44 (0) 20 3709 5700 Mary-Jane Elliott / Matthew Neal / Nicholas Brown / Olivia Manser Investec Bank PLC - Nominated Adviser & Tel: +44 (0) 20 7597 Broker 5970 Daniel Adams / Patrick Robb / Gary Clarence
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BLRUPUBPWUPUGBB
(END) Dow Jones Newswires
March 10, 2020 03:00 ET (07:00 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions